Sublingual strips, transdermal sticker patches, and powder sticks — targeted at four need states (Brain, Gut, Calm, Sleep) with a character licensing moat.
Need-based kids supplements via strips + sticker patches is a genuine white-space play. No US brand owns this position. Unit economics are elite. The licensing play on patches creates a moat that gummies can never replicate.
The category is large, growing, and underserved by format innovation. Post-pandemic, parents became 48% more likely to supplement their kids. The entire market is still dominated by gummies and chewable tablets. No one owns strips or patches for kids in the US.
Addressable segment: Need-based functional kids supplements (brain, gut, calm, sleep) — estimated $190–250M in the US.
Not all delivery methods are created equal. The same vitamin can be 1% bioavailable or 91% bioavailable depending on how it enters the body.
Bioavailability = the percentage of an active ingredient that actually reaches your bloodstream. IV delivery is the 100% benchmark. The biggest enemy is first-pass metabolism: stomach acid → intestinal wall → liver. Each step destroys a portion of the active ingredient. Sublingual and transdermal bypass this entirely.
| # | Delivery Method | Bioavailability | Onset | Bypasses First-Pass? |
|---|---|---|---|---|
| 01 | IV Injection | Seconds | Yes — direct to blood | |
| 02 | IM Injection | 10–20 min | Yes | |
| 03 | Sublingual Strip | 30 sec–3 min | Yes — bypasses liver | |
| 04 | Transdermal Patch / Sticker | 1–8 hrs (sustained) | Yes — bypasses liver | |
| 05 | Intranasal (Spray) | 5–15 min | Mostly | |
| 06 | Rectal | 15–30 min | Partially | |
| 07 | Powder (dissolved) | 15–30 min | No | |
| 08 | Liquid / Drops | 15–30 min | No | |
| 09 | Chewable Tablet | 20–45 min | No | |
| 10 | Gummy | 20–45 min | No | |
| 11 | Hard-Pressed Pill | 30–60 min | No | |
| 12 | Topical Cream | Variable | Yes (local) |
*Gummy potency degrades 20–40% within 6–12 months. Real-world bioavailability is lower than fresh. Sources: NIH StatPearls, PMC4977085, Springer Pharmaceutical Research, PubMed 3958225.
The tissue under the tongue is just a few cell layers thick and rich with capillaries. Substances dissolve and pass directly into the bloodstream — completely bypassing the stomach, intestines, and liver.
Transdermal delivery is proven medicine — not a wellness fad. The FDA has approved patches for some of the most critical drugs in healthcare.
90% bioavailability. Sustained delivery for 72 hours. FDA-approved. (NIH StatPearls)
FDA-approved since 1991. Proven sustained-release delivery through skin for smoking cessation.
FDA-approved since 1986. Gold standard for hormone replacement therapy via transdermal delivery.
Sustained physiological levels vs oral spike-and-crash. Superior for sleep maintenance. (PMC2909186)
Small molecules under 500 Dalton: melatonin ✅, B vitamins ✅, zinc ✅, magnesium ✅, adaptogens ✅
Large molecules: omega-3s ❌, probiotics ❌, most proteins ❌. Transdermal is molecule-dependent — which is exactly why we formulate each patch for its specific need state.
Every winner in kids supplements ran the same play: one hero multivitamin, subscription, DTC. That playbook is maxed out.
They all asked: “Does your kid take a multivitamin?” A multivitamin is a blunt instrument. Every kid gets the same 15 vitamins whether they need help with focus, gut health, anxiety, or sleep.
The adult market already made this transition. Care/of, Persona, and Ritual built businesses on personalized, need-based stacking. The adult personalized nutrition market:
This hasn’t happened in kids yet. No brand has given parents a system where they pick the need state for their kid and build a daily routine. Hiya’s expansion into bedtime/probiotics/iron proves demand exists — but they’re bolting on SKUs, not building a system.
We don’t ask “does your kid take a vitamin?”
We ask “what does your kid need?”
Brain. Gut. Calm. Sleep. Pick the need, get the right format, build the routine. The brand IS the routine.
Gummies dominate 60% of kids supplements. They're one of the worst delivery mechanisms ever designed for children's health.
Gelatin sticks to enamel. 2–4g sugar per gummy. Pediatric dentists now actively warn parents away. Distinctive multi-tooth decay patterns.
20–40% active ingredient loss within 6–12 months. Capsules maintain 90–95% for 2–3 years. The gel matrix is inherently unstable.
Active amounts vary gummy to gummy. Manufacturers "overage" to compensate for degradation. Precise dosing is impossible.
Thousands of Poison Control calls annually from kids who eat entire bottles. You're conditioning medicine = sugar.
Known risk for children under 3–4. Parents cut gummies into pieces or skip supplements entirely. Terrible UX.
Probiotics, minerals, and higher-dose functional ingredients don't survive gummy manufacturing (high heat + moisture).
Four need states × three delivery formats. Each format optimized for what it does best.
Fast-dissolving, 35–91% bioavailability, zero sugar, no choking risk. Kids think they're cool. 4 SKUs.
Collectible character designs, 8–12 hr sustained release, bypasses gut. Kids ASK for them. The licensing play. 4 SKUs.
Fruit-flavored, mix into water/juice. Great for ages 2–4. Retail-friendly. Entry to subscription. 2–4 SKUs.
Not every ingredient works in every format. When you map the molecular science to each need state, a sharper architecture emerges.
DHA is oily and needs GI lipases. Phosphatidylserine is 750 Da (above patch cutoff). Iron tastes terrible in strips. Powder is the only viable format.
Probiotics are living organisms that MUST reach the gut. Sublingual bypasses it entirely. Organisms can’t cross skin. Powder is the only option.
L-theanine (174 Da) is an ideal sublingual candidate. Magnesium is THE proven transdermal nutrient. Best use case for both formats.
Mg patch delivers sustained all-night release. Glycine (75 Da) is tiny and sweet — ideal strip. Format advantage is maximized.
| Need State | Lead Format | Support | Why |
|---|---|---|---|
| 🧠 Brain | Powder Stick | — | Only format for DHA + PS + iron |
| 🦠 Gut | Powder Stick | — | Probiotics must physically reach the gut |
| 😌 Calm | Sublingual Strip | Mg Patch | L-theanine absorbs 2–3× faster sublingually |
| 😴 Sleep | Sticker Patch | Glycine Strip | Sustained Mg release all night; glycine for fast onset |
“We engineered each product in the format that maximizes bioavailability for that specific ingredient.” Wins pediatricians and informed parents.
6 products instead of 12. Lower manufacturing complexity. Faster time to market. Focused inventory.
“Why is Sleep a patch?” “Because sustained-release magnesium keeps levels steady all night instead of spiking.”
Sticker patches hero Sleep. Powder sticks carry character art on packaging. Collectibility isn’t lost.
| Product | COGS | Price | GP | Margin |
|---|---|---|---|---|
| Strip Pack (30ct) | $3.60 | $16.99 | $13.39 | 78.8% |
| Patch Pack (30ct) | $6.90 | $19.99 | $13.09 | 65.5% |
| Combo Bundle | $10.50 | $29.99 | $19.49 | 65.0% |
| Blended AOV | $6.84 | $22.99 | $16.15 | 70.2% |
Combo subscriber LTV: $319 revenue / $187 GP over 12.5-month average lifetime.
| CAC | LTV:CAC | Payback |
|---|---|---|
| $25 | 7.5× | 1.7 months |
| $35 | 5.4× | 2.3 months |
| $50 | 3.7× | 3.3 months |
| $75 | 2.5× | 5.0 months |
Patches-as-stickers create a format that is collectible, shareable, defensible, and seasonal. Character licensing is the moat.
Original characters per need state. No royalty drag. Test product-market fit. Collectible element: kids collect all four.
Sesame Street, Paw Patrol, CoComelon, Bluey. 8% royalty. Margins stay 64–74%. 30–50% higher conversion.
Disney/Pixar, Marvel, Pokémon. Limited-edition drops. Urgency + collectibility. Wellbeing Nutrition (India) already has Marvel — proves the path.
Even with 8% licensing royalty, margins stay 65%+ due to low strip/patch COGS. Licensed characters drive 30–50% higher conversion on kids products.
At $35 blended CAC with ~27K new customers in Year 1, the business generates $995K gross profit — self-sustaining on unit economics alone. Year 2 licensing drives 30–40% conversion lift and retail expansion.